Analysis of p16INK4A expression of oral squamous cell carcinomas in Taiwan: Prognostic correlation without relevance to betel quid consumption

Journal of Surgical Oncology

Volumn 106, Issue 2, 2012, Pages 149-154

  Chen, Ya Wei ^a,b   Kao, Shou Yen ^a,b   Yang, Muh Hwa ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

betel quid; oral squamous cell carcinoma; p16INK4A; prognosis

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER;

ADULT; AGED; ARTICLE; BETEL NUT; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DOWN REGULATION; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MASTICATION; MOUTH SQUAMOUS CELL CARCINOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TAIWAN; WART VIRUS;

ADULT; AGED; ARECA; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; HABITS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL; TAIWAN; TUMOR MARKERS, BIOLOGICAL;

EID: 84863717575     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23067     Document Type: Article

References (33)

1. Genden EM, Ferlito A, Bradley PJ, et al.: Neck disease and distant metastases. Oral Oncol 2003; 39: 207-212. (Pubitemid 36255686)
2. Edwards BK, Ward E, Kohler BA, et al.: Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010; 116: 544-573.
3. Franceschi S, Bidoli E, Herrero R, et al.: Comparison of cancers of the oral cavity and pharynx worldwide: Etiological clues. Oral Oncol 2000; 36: 106-115.
4. Koenig A, Linhart T, Schlengemann K, et al.: NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells. Gastroenterology 2010; 138: 1189-1199, e1181-e1182.
5. Albert M, Helin K,: Histone methyltransferases in cancer. Semin Cell Dev Biol 2010; 21: 209-220.
6. Liao CT, Chang JT, Wang HM, et al.: Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol 2008; 15: 915-922.
7. Lo WL, Kao SY, Chi LY, et al.: Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: Factors affecting survival. J Oral Maxillofac Surg 2003; 61: 751-758.
8. Mendenhall WM, Logan HL,: Human papillomavirus and head and neck cancer. Am J Clin Oncol 2009; 32: 535-539.
9. Koh VM, Shi YX, Tang QH,: P16 and retinoblastoma protein expression in endometrial carcinoma and clinical significance. Eur J Gynaecol Oncol 2011; 32: 309-315.
10. Maruschke M, Thur S, Kundt G, et al.: Immunohistochemical expression of retinoblastoma protein and p16 in renal cell carcinoma. Urol Int 2011; 86: 60-67.
11. Arima Y, Hayashi N, Hayashi H, et al.: Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor-negative breast cancer. Int J Cancer 2011; [Epub ahead of print].
12. Klussmann JP, Gultekin E, Weissenborn SJ, et al.: Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003; 162: 747-753. (Pubitemid 36237483)
13. Strati K, Pitot HC, Lambert PF,: Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model. Proc Natl Acad Sci USA 2006; 103: 14152-14157. (Pubitemid 44452995)
14. Robinson M, Sloan P, Shaw R,: Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing. Oral Oncol 2010; 46: 492-496.
15. Abrahao AC, Bonelli BV, Nunes FD, et al.: Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders. Braz Oral Res 2011; 25: 34-41.
16. Buajeeb W, Poomsawat S, Punyasingh J, et al.: Expression of p16 in oral cancer and premalignant lesions. J Oral Pathol Med 2009; 38: 104-108.
17. Karsai S, Abel U, Roesch-Ely M, et al.: Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis. J Pathol 2007; 211: 314-322. (Pubitemid 46172707)
18. Shah NG, Trivedi TI, Tankshali RA, et al.: Prognostic significance of molecular markers in oral squamous cell carcinoma: A multivariate analysis. Head Neck 2009; 31: 1544-1556.
19. Lee CH, Ko YC, Huang HL, et al.: The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Br J Cancer 2003; 88: 366-372.
20. Koch WM, Lango M, Sewell D, et al.: Head and neck cancer in nonsmokers: A distinct clinical and molecular entity. Laryngoscope 1999; 109: 1544-1551. (Pubitemid 29477216)
21. Herrero R, Castellsague X, Pawlita M, et al.: Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003; 95: 1772-1783. (Pubitemid 38008900)
22. Yang MH, Hsu DS, Wang HW, et al.: Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 2010; 12: 982-992.
23. Kumar B, Cordell KG, Lee JS, et al.: EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008; 26: 3128-3137.
24. Licitra L, Perrone F, Bossi P, et al.: High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006; 24: 5630-5636. (Pubitemid 46631302)
25. Nichols AC, Faquin WC, Westra WH, et al.: HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 2009; 140: 228-234.
26. Arafa M, Boniver J, Delvenne P,: Detection of HPV-induced cervical (pre) neoplastic lesions: A tissue microarray (TMA) study. Appl Immunohistochem Mol Morphol 2008; 16: 422-432.
27. Chang KW, Chang CS, Lai KS, et al.: High prevalence of human papillomavirus infection and possible association with betel quid chewing and smoking in oral epidermoid carcinomas in Taiwan. J Med Virol 1989; 28: 57-61. (Pubitemid 19146243)
28. INK4A in oral squamous cell carcinomas-a correlation with biological behaviors: Immunohistochemical and FISH analysis. J Oral Maxillofac Surg 2006; 64: 1617-1623. (Pubitemid 44556954)
29. Sinha P, Bahadur S, Thakar A, et al.: Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue. Head Neck 2009; 31: 1423-1430.
30. Hoshino I, Matsubara H,: Recent advances in histone deacetylase targeted cancer therapy. Surg Today 2010; 40: 809-815.
31. Smith EM, Rubenstein LM, Hoffman H, et al.: Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer. Infect Agent Cancer 2010; 5: 4.
32. Woolgar JA,: Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 2006; 42: 229-239. (Pubitemid 43246755)
33. Mendelsohn AH, Lai CK, Shintaku IP, et al.: Histopathologic findings of HPV and p16 positive HNSCC. Laryngoscope 2010; 120: 1788-1794.